2 August 2022
DLA Piper advises Brookline Capital Acquisition Corp. in the closing of its business combination with Apexigen, Inc.
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jeffrey Selman Lead | DLA Piper | Partner | SPAC Transactional | San Francisco |
| James Kelly | DLA Piper | Partner | Private Equity | New York |
| Peter Ekberg | DLA Piper | Partner | Not stated | Minneapolis |
| Alan Seem | DLA Piper | Partner | Not stated | Silicon Valley |
| Carole Bellis | DLA Piper | Partner | Not stated | Silicon Valley |
| Ilya Bubel | DLA Piper | Partner | Not stated | New York |
| Spencer Hodson | DLA Piper | Associate | Not stated | Sacramento |
| Wei Li | DLA Piper | Associate | Not stated | Silicon Valley |
| Peter Phillips | DLA Piper | Associate | Not stated | New York |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Brookline Capital Acquisition Corp.Buy-side
- Counterparties
- Apexigen, Inc. (Sell-side)